MyJournals Home  

RSS FeedsNCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24 (Cancer Biotherapy & Radiopharmaceuticals)

 
 

7 december 2019 07:00:08

 
NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24 (Cancer Biotherapy & Radiopharmaceuticals)
 


Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.


 
230 viewsCategory: Biotechnology, Oncology, Pharmacology
 
Preliminary Studies of 177Lu-Diethylenetriamine Penta-Acetic Acid-Deoxyglucose in Hepatic Tumor-Bearing Mice (Cancer Biotherapy & Radiopharmaceuticals)
Small Animal PET Imaging of hTERT RNA-Targeted HSV1-tk Gene Expression with Trans-Splicing Ribozyme (Cancer Biotherapy & Radiopharmaceuticals)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten